E5 - Obesity Flashcards

1
Q

What is obesity?

A
  • Too much body fat
  • Too much fat in the ‘wrong’ place
  • Energy intake > Energy requirements
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How can obesity be measured?

A
  • BMI (weight in kg/height in m^2)

- Skin folds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is assumed when measuring skin folds, and where is it measured?

A
  • Assumes constant relationship between subcutaneous and total body fat
  • Can be measured all over the body; biceps + triceps commonly used
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the consequences of obesity on the body?

A
  • Increases BP
  • Increases plasma cholesterol
  • Is a major risk factor for CHD
  • Increases risk of T2DM (additional risk factor for CHD)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How is waist circumference used to predict risk?

A
  • Good measure of intra-abdominal fat
  • If apple or pear-shaped = fat sitting on waist
  • Greater risk of complications if apple-shaped
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How is obesity treated?

A
  • Dietetic treatment
  • Drugs
  • Surgery
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What dietetic treatments are availible?

A
  • Very low calorie diets (VLCDs)

- Individualised modest energy restrictive diet

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What do VLCDs involve and its respective advantages/disadvantages?

A
  • Commercially-prepared diet typically 500 kcal/day for several days/weeks (max 12 weeks)
  • Medical supervision only
  • For v. obese patients that need to lose weight quickly (e.g. life threatening/in order to undergo surgery)
  • Milkshake-type preparation (protein, vitamins, minerals)

Adv:
- Rapid weight loss if compliant

Dis:
- Not teaching healthy eating

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What do Individualised Modest Energy Restrictive Diets entail?

A
  • Provides 500 kcal/day less than calculated energy balance
  • Slower weight loss, but based on healthy eating guidelines (patient education)
  • Provides correct balance of nutrients
  • Based on age/sex/weight
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the only current POM drug licensed to treat obesity and its mechanism of action?

A

Orlistat (tetrahydrolipostatin):

  • Inhibits gastric & pancreatic lipase
  • Thus preventing metabolism of fat; not absorbed and excreted in faeces
  • 30% lipase inhibition at normal therapeutic dose (= losing 2kcal/day)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How should Orlistat be taken and what is its side effect profile?

A
  • To be taken before each meal
  • Combine with a low fat diet

Side effects:

  • Steatorrhoea (fatty, foul faeces; can result in leakage)
  • Reduced absorption of fat = monitor fat soluble vitamins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What criteria must a patient fall under to be prescribed Orlistat?

A
  • BMI > 30 kg/m^2
  • Or BMI > 28 kg/m^2 with other risk factors e.g. T2DM, hypercholesterolaemia, hypertension
  • Treatment only continued after 12 weeks if weight loss exceeds 5%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the ideal weight loss target?

A
  • 5-10% of original weight

- MAX weekly weight loss of 0.5 - 1kg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What were the other POMs licensed (until Jan 2010 and Oct 2008 respectively)?

A
  • Sibutramine

- Rimonabant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the mechanism of action of Sibutramine (suspended Jan 2010) and its side effect profile?

A
  • Combined NA and 5HT uptake inhibitor
  • Appetite suppressant
  • Herbal products often contain it

Side effects:

  • Increases SNS activity, can raise BP (increased NA in periphery as well as brain)
  • Increases heart rate slightly
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the mechanism of action for the now-withdrawn Rimonabant and why was it withdrawn?

A
  • CB1 receptor antagonist ‘inhibits munchies’
  • Blocks central AND peripheral CB1 receptors
    »> CNS side effect; depression/suicidal
17
Q

What bariatric surgery options are availible?

A
  • Roux-en-Y gastric bypass (RYGB)

- Laparoscopic adjustable gastric banding (LAGB)

18
Q

What are the beneficial results from bariatric surgery?

A

Reduces mortality/morbidity in morbidly obese:

  • Improves T2DM
  • Reduces hyperlipidaemia
  • Reduces hypertension
  • Improves sleep apnoea

Surgery leads to:

  • Major, sustained weight loss
  • Increased satiety and reduced appetite
19
Q

What are the risks associated with bariatric surgery?

A
  • 1% early mortality after RYGBP surgery

- 0.4% early mortality after banding